Transcriptomic Signatures of Progression to Tuberculosis Disease Among Close Contacts in Brazil
The Journal of Infectious Diseases · 16.12.2024 · 230 (6) · e1355-e1365
DOI: 10.1093/infdis/jiae237 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 06.05.2024. Verfasst von Simon C Mendelsohn und 15 weiteren Autor:innen. Beteiligte Einrichtung: South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, and Division of Immunology, Department of Path…. Hauptthemen laut MEDLINE: Transcriptome, Disease Progression, Mycobacterium tuberculosis. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, CRDF Global, Departamento de Ciência e Tecnologia.
Abstract (Originalsprache)
Background
Approximately 5% of people infected with Mycobacterium tuberculosis progress to tuberculosis (TB) disease without preventive therapy. There is a need for a prognostic test to identify those at highest risk of incident TB so that therapy can be targeted. We evaluated host blood transcriptomic signatures for progression to TB disease.
Methods
Close contacts (≥4 hours of exposure per week) of adult patients with culture-confirmed pulmonary TB were enrolled in Brazil. Investigation for incident, microbiologically confirmed, or clinically diagnosed pulmonary or extrapulmonary TB disease through 24 months of follow-up was symptom triggered. Twenty previously validated blood TB transcriptomic signatures were measured at baseline by real-time quantitative polymerase chain reaction. Prognostic performance for incident TB was tested by receiver operating characteristic curve analysis at 6, 9, 12, and 24 months of follow-up.
Results
Between June 2015 and June 2019, 1854 close contacts were enrolled. Twenty-five progressed to incident TB, of whom 13 had microbiologically confirmed disease. Baseline transcriptomic signature scores were measured in 1789 close contacts. Prognostic performance for all signatures was best within 6 months of diagnosis. Seven signatures (Gliddon4, Suliman4, Roe3, Roe1, Penn-Nicholson6, Francisco2, and Rajan5) met the minimum World Health Organization target product profile for a prognostic test through 6 months and 3 signatures (Gliddon4, Rajan5, and Duffy9) through 9 months. None met the target product profile threshold through ≥12 months of follow-up.
Conclusions
Blood transcriptomic signatures may be useful for predicting TB risk within 9 months of measurement among TB-exposed contacts to target preventive therapy administration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
- Laboratório de Pesquisa Clínica e Translacional, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
- Vanderbilt University Medical Center, Nashville, Tennessee.
- Laboratorio de Pesquisa Clinica em Micobacterioses, Instituto Nacional de Infectologia Evandro Chagas, Fiocruz, Rio de Janeiro, Brazil.
- Fundação de Medicina Tropical Doutor Heitor Vieira Dourado, Manaus, Brazil.
- FIND, Geneva, Switzerland.
ORCID-Profile: Simon C Mendelsohn, Bruno B Andrade, Stanley Kimbung Mbandi, Valeria C Rolla, Prisca K Thami, Marcelo Cordeiro-Santos, Adam Penn-Nicholson, Mark Hatherill, Timothy R Sterling, Thomas J Scriba
Förderung
- NIAID NIH HHS
- CRDF Global
- Departamento de Ciência e Tecnologia
- Ministério da Saúde
- Secretaria de Ciência e Tecnologia
- US National Institutes of Health
Zitieren
APA
Mendelsohn, S. C., Andrade, B. B., Mbandi, S. K., Andrade, A. M. S., Muwanga, V. M., Figueiredo, M. C., Erasmus, M., Rolla, V. C., Thami, P. K., Cordeiro-Santos, M., Penn-Nicholson, A., Kritski, A. L., Hatherill, M., Sterling, T. R., Scriba, T. J., & RePORT–South Africa and RePORT–Brazil Consortia (2024). Transcriptomic Signatures of Progression to Tuberculosis Disease Among Close Contacts in Brazil. The Journal of Infectious Diseases, 230(6), e1355-e1365. https://doi.org/10.1093/infdis/jiae237
Vancouver
Mendelsohn SC, Andrade BB, Mbandi SK, Andrade AMS, Muwanga VM, Figueiredo MC, et al. Transcriptomic Signatures of Progression to Tuberculosis Disease Among Close Contacts in Brazil. The Journal of Infectious Diseases. 2024;230(6):e1355-e1365. doi:10.1093/infdis/jiae237
BibTeX
@article{Mendelsohn2024,
author = {Mendelsohn, Simon C and Andrade, Bruno B and Mbandi, Stanley Kimbung and Andrade, Alice M S and Muwanga, Vanessa M and Figueiredo, Marina C and Erasmus, Mzwandile and Rolla, Valeria C and Thami, Prisca K and Cordeiro-Santos, Marcelo and Penn-Nicholson, Adam and Kritski, Afranio L and Hatherill, Mark and Sterling, Timothy R and Scriba, Thomas J and RePORT–South Africa and RePORT–Brazil Consortia, RePORT–South Africa and RePORT–Brazil Consortia},
title = {Transcriptomic Signatures of Progression to Tuberculosis Disease Among Close Contacts in Brazil},
journal = {The Journal of Infectious Diseases},
year = {2024},
volume = {230},
number = {6},
pages = {e1355--e1365},
doi = {10.1093/infdis/jiae237}
}
EUVIMED